Physician

None

According to 2025 Medicare claims, NPI 1710923040 (NPI: 1710923040) practices general practice in the Youngstown-Warren, OH market, with the plurality of this provider's patient population coming from Mahoning, OH. 1710923040 uses personal NPI as billing NPI and primary practice location at 44514-9998.

1710923040's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 112 traditional Medicare patients, billed 699 HCPCS/CPT codes, and received $30,685 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 11,362 prescription claims across 519 beneficiaries totaling $931,325 in drug costs, led by Eliquis (Apixaban). DME data shows 134 claims. Open Payments data shows 86 records totaling $1,569. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $61,656 to $30,685. In contrast, Part D prescription costs have risen steadily, from $489,479 to $931,325. For DME billing, this smaller-volume category moved up and down with repeated peaks and valleys, starting at $4,081 and ending at $3,852.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	211	2,586	$61,656
2016	232	2,693	$68,791
2017	245	2,563	$69,070
2018	235	2,807	$83,081
2019	226	2,385	$77,841
2020	196	1,662	$54,372
2021	184	1,543	$58,047
2022	178	1,365	$53,692
2023	132	760	$31,855
2024	112	699	$30,685

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	425	9,593	$489,479
2016	445	10,481	$528,268
2017	468	10,505	$522,843
2018	483	10,997	$641,963
2019	538	11,714	$775,628
2020	539	10,885	$745,196
2021	541	10,970	$763,937
2022	572	11,504	$826,930
2023	557	11,690	$927,439
2024	519	11,362	$931,325

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	37	178	$9,548
2016	40	165	$4,454
2017	34	181	$5,366
2018	33	228	$6,309
2019	33	137	$4,520
2020	17	182	$4,554
2021	11	194	$14,794
2022	12	226	$14,536
2023	178	371	$1,195,287
2024	N/R	134	$7,432

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	30	40	$82
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	101	286	$56
G0008	Administration of influenza virus vaccine	19	19	$25
96372	Injection of drug or substance under skin or into muscle	20	26	$9
J1100	Injection, dexamethasone sodium phosphate, 1 mg	26	46	$0

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	258	8,277	$158,605
Jardiance	Empagliflozin	145	7,031	$137,618
Ozempic	Semaglutide	98	3,213	$105,411
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	74	2,280	$49,157
Aptiom	Eslicarbazepine Acetate	22	662	$40,188

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7606	Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms	N	N/R	24	$3,473
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	21	$1,542
J7626	Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg	N	N/R	25	$1,306
Q0513	Pharmacy dispensing fee for inhalation drug(s); per 30 days	N	N/R	31	$776
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	N/R	22	$320

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	86	$1,569	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for NPI 1710923040?

Tedicare shows public-source Medicare data for NPI 1710923040 (NPI 1710923040), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does NPI 1710923040 have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to NPI 1710923040?

A separate primary affiliated billing organization is not shown for this profile in the available data.

Does NPI 1710923040 have Open Payments data?

NPI 1710923040 has 86 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.